Role of aripiprazole in treating mood disorders
Abstract
Atypical antipsychotics have been used to treat patients with schizophrenia for many years, but now there is increasing evidence of their utility in the treatment of mood disorders. In the past few years, several atypical agents have received regulatory approval for use in mania. The evidence shows that atypical antipsychotics are effective in the treatment of manic symptoms, either alone or in combination with traditional mood stabilizers, such as lithium and divalproex. Although emerging data indicate that atypical antipsychotics will be a promising addition to those therapies that are currently available for managing patients during the maintenance phase of bipolar illness, their potential in the long-term management of bipolar disorder remains to be fully explored. Aripiprazole is a recently released antipsychotic medication that differs from other atypical antipsychotic agents by its mode of action as a dopamine D2 partial agonist. It is administered orally and has a long half-life. Randomized studies have demonstrated the efficacy of aripiprazole compared with placebo in the treatment of acute relapse of schizophrenia and schizoaffective disorder, maintenance treatment of schizophrenia, treatment of acute mania, and prevention of manic relapse in patients who responded to the drug during a manic episode. Further studies are ongoing in bipolar and unipolar depression. Aripiprazole is generally well tolerated compared with other antipsychotic medications, although commonl…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Randomized controlled trials have demonstrated efficacy for second-generation antipsychotics in the treatment of acute mania in bipolar disorder.
“Randomized, controlled trials have demonstrated efficacy for second-generation antipsychotics in the treatment of acute mania in bipolar disorder.”
From Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis (2010) · cites this paper as Garcia-Amador et al. 2006
Cites
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554 · see citing works
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., LAUGHREN, T. P., & Katz, R. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204 · see citing works
Kapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.514 · Cited by 1,090 · see citing works
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S. M., Arrington, E. G., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 971 · see citing works
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908 · see citing works
Self-citationCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883 · see citing works
Kapur, S., Zipursky, R. B., & Remington, G. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.286 · Cited by 711 · see citing works
Kane, J. M., Carson, W. H., Saha, A. R., McQuade, R. D., Ingenito, G. G., ZIMBROFF, D. L., & Ali, M. W. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0903 · Cited by 624 · see citing works
Potkin, S. G., Saha, A. R., Kujawa, M. J., Carson, W. H., Ali, M. W., Stock, E. G., Stringfellow, J., Ingenito, G. G., & Marder, S. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.681 · Cited by 592 · see citing works
Keck, P. E., Marcus, R. N., Tourkodimitris, S., Ali, M. W., Liebeskind, A., Saha, A. R., Ingenito, G. G., & Aripiprazole Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1651 · Cited by 501 · see citing works
Kasper, S. F., Lerman, M. N., McQuade, R. D., Saha, A. R., Carson, W. H., Ali, M. W., Archibald, D., Ingenito, G. G., Marcus, R. N., & Pigott, T. A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003651 · Cited by 309 · see citing works
Keck, P. E., Calabrese, J. R., McQuade, R. D., Carson, W. H., Carlson, B. X., Rollin, L. M., Marcus, R. N., Sanchez, R., & Aripiprazole Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0414 · Cited by 290 · see citing works
Self-citationSachs, G. S., Sanchez, R., Marcus, R. N., Stock, E. G., McQuade, R. D., Carson, W. H., Abou-Gharbia, N., Impellizzeri, C., Kaplita, S., Rollin, L., et al. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106059693 · Cited by 245 · see citing works
Self-citationMcQuade, R. D., Stock, E. G., Marcus, R. N., Jody, D. N., Abou-Gharbia, N., Vanveggel, S., Archibald, D., & Carson, W. H. (2004) · PubMed · Cited by 244 · see citing works
Mechanism of New Antipsychotic Medications
Gründer, G., Carlsson, A., & Wong, D. F. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.10.974 · Cited by 199 · see citing works
Effectiveness of aripiprazole v. Haloperidol in acute bipolar mania
Vieta, E., Bourin, M., Sanchez, R., Marcus, R. N., Stock, E. G., McQuade, R. D., Carson, W. H., Abou-Gharbia, N., Swanink, R., & Iwamoto, T. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.3.235 · Cited by 171 · see citing works
Self-citationAtypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham, L. N., Goldstein, J. M., Vieta, E., Bowden, C. L., Grunze, H., Post, R. M., Suppes, T. M., & Calabrese, J. R. (2005) · PubMed · Cited by 159 · see citing works
Self-citationAripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology
Davies, M. A., Sheffler, D. J., & Roth, B. L. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00030.x · Cited by 158 · see citing works
Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile
Hirose, T., Uwahodo, Y., Yamada, S., Miwa, T., Kikuchi, T., Kitagawa, H., Burris, K. D., Altar, C. A., & Nabeshima, T. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800308 · Cited by 128 · see citing works
Papakostas, G. I., Petersen, T., Kinrys, G., Burns, A. M., Worthington, J. J., Alpert, J. E., D, M. F. M., & Nierenberg, A. A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1017 · Cited by 125 · see citing works
Impact of Atypical Antipsychotics on Quality of Life in Patients with Schizophrenia
Awad, A. G., & Voruganti, L. N. P. (2004) · CNS Drugs · doi:10.2165/00023210-200418130-00004 · Cited by 124 · see citing works
Simon, J. S., & Nemeroff, C. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1002 · Cited by 103 · see citing works
Barzman, D. H., DelBello, M. P., Kowatch, R. A., Gernert, B., Fleck, D. E., Pathak, S., Rappaport, K., Delgado, S. V., Campbell, P., & Strakowski, S. M. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.593 · Cited by 100 · see citing works
Atypical antipsychotics: newer options for mania and maintenance therapy
Vieta, E., & Goikolea, J. M. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00212.x · Cited by 89 · see citing works
Self-citationPharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate
Citrome, L., Josiassen, R. C., Bark, N. M., Salazar, D. E., & Mallikaarjun, S. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004269870 · Cited by 85 · see citing works
Aripiprazole in the Treatment of Pediatric Bipolar Disorder: A Systematic Chart Review
Biederman, J., McDonnell, M. A., Wozniak, J. R., Spencer, T. J., Aleardi, M., Falzone, R., & Mick, E. O. (2005) · CNS Spectrums · doi:10.1017/s1092852900019489 · Cited by 75 · see citing works
Adjunctive Aripiprazole in Treatment-Resistant Bipolar Depression
Ketter, T. A., Wang, P. W., Chandler, R. A., Culver, J. L., & Alarcon, A. M. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600801176 · Cited by 63 · see citing works
Aripiprazole and neuroleptic malignant syndrome
Chakraborty, N., & Johnston, T. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200411000-00007 · Cited by 63 · see citing works
Aripiprazole: pharmacology, efficacy, safety and tolerability
Kinghorn, W. A., & McEvoy, J. P. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.3.297 · Cited by 55 · see citing works
Aripiprazole Augmentation in Treatment-Resistant Depression
Barbee, J. G., Conrad, E. J., & Jamhour, N. J. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490521954 · Cited by 54 · see citing works
Atypical antipsychotics in bipolar depression: Neurobiological basis and clinical implications
Brugue, E., & Vieta, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.014 · Cited by 54 · see citing works
Self-citationBipolar mixed states and their treatment
Vieta, E. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.1.63 · Cited by 45 · see citing works
Self-citationAtypical antipsychotics in the treatment of mood disorders
Vieta, E. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200301000-00006 · Cited by 33 · see citing works
Self-citationLyseng-Williamson, K. A., & Perry, C. M. (2004) · CNS Drugs · doi:10.2165/00023210-200418060-00007 · Cited by 32 · see citing works
Atypical antipsychotics in mood disorders.
Kasper, S. F., Stamenkovic, M., Letmaier, M., & Schreinzer, D. (2002) · PubMed · Cited by 18 · see citing works
Maintenance therapy for bipolar disorder: current and future management options
Vieta, E. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.6.s35 · Cited by 16 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Treatment of bipolar disorder: a systematic review of available data and clinical perspectives
Fountoulakis, K. Ν., & Vieta, E. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009231 · Cited by 172 · see citing works
Self-citationEfficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry
Fountoulakis, K. Ν., Kasper, S. F., Andreassen, O. A., Blier, P., Okasha, A., Severus, E., Versiani, M., Tandon, R., Möller, H., & Vieta, E. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0323-x · Cited by 130 · see citing works
Self-citationCruz, N., Sanchez-Moreno, J., Torres, F., Goikolea, J. M., Valentí, M., & Vieta, E. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990344 · Cited by 121 · see citing works
Self-citationAripiprazole monotherapy in the treatment of bipolar disorder: A meta-analysis
Fountoulakis, K. N., Vieta, E., & Schmidt, F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.018 · Cited by 52 · see citing works
Self-citationEfficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
Fountoulakis, K. Ν., & Vieta, E. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-16 · Cited by 45 · see citing works
Self-citationTsai, A. C., Rosenlicht, N. Z., Jureidini, J. N., Parry, P. I., Spielmans, G. I., & Healy, D. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000434 · Cited by 43 · see citing works
Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials
Arbaizar, B., Dierssen‐Sotos, T., Gómez‐Acebo, I., & Llorca, J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.05.005 · Cited by 28 · see citing works
Kumar, M., Mehan, S., Kumar, A., Sharma, T., Khan, Z., Tiwari, A., Gupta, G. D., & Narula, A. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149251 · Cited by 25 · see citing works
Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis
Fountoulakis, K. Ν., Gonda, X., Vieta, E., & Schmidt, F. M. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-27 · Cited by 21 · see citing works
Self-citationClass effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Fountoulakis, K. Ν., Gonda, X., Vieta, E., & Rihmer, Z. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-8 · Cited by 21 · see citing works
Self-citationAripiprazole for the treatment of bipolar disorder: a review of current evidence
Fagiolini, A. M., Nitti, M. P., Forgione, R. N., Marra, F. S., & Casamassima, F. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.552429 · Cited by 12 · see citing works
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
Muzina, D. J. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3763 · Cited by 8 · see citing works
[Advances in the treatment of mania: aripiprazole].
Vieta, E., & Franco, C. (2008) · PubMed · Cited by 5 · see citing works
Self-citationAkhavanrezayat, A., Hebrani, P., Behdani, F., Salaran, M., & Marvast, M. N. (2014) · Europe PMC (PubMed Central) · Cited by 4 · see citing works
Lum, J. S., Pan, B., Deng, C., Huang, X., Ooi, L., & Newell, K. A. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.048 · Cited by 3 · see citing works
Stratégie TDAE appliquée à la synthèse de candidats–médicaments
Terme, T., & Vanelle, P. (2008) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2008.03.001 · Cited by 2 · see citing works
Treating Bipolar Disorder in the Primary Care Setting
Manning, J. S., & McElroy, S. L. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08r00635 · Cited by 2 · see citing works
Chandrika, P., Sethuvasan, S., Santhosh, P., Kesavan, M., Aswathy, K. A., Ganesh, M. R., & Ponnuswamy, S. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141376 · Cited by 1 · see citing works
The use of atypical antipsychotic drugs in Bipolar II disorder
Vieta, E., & Cruz, N. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.013 · Cited by 1 · see citing works
Self-citationNovel Antipsychotic Drugs Approved in 2015: Brexpiprazole, Cariprazine, Aripiprazole Lauroxil
Kuş, C. (2016) · Medicinal Chemistry · doi:10.4172/2161-0444.1000380 · Cited by 1 · see citing works
The use of atypical antipsychotic drugs in Bipolar II Disorder
Fresno, D., & Vieta, E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.012 · Cited by 1 · see citing works
Self-citationStajić, M., & Maksimović, Ž. (2019) · Scripta Medica · doi:10.5937/scriptamed50-22410 · Cited by 1 · see citing works
Alberdi, G., & Manuel, J. (2012) · TDX (Tesis Doctorals en Xarxa)
Pharmacological Management of Manic Episodes
Vieta, E. (2013) · doi:10.1007/978-1-908517-94-4_8
Self-citationThe Use of Antipsychotic Drugs in Bipolar II Disorder
Vieta, E. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108333252.014
Self-citation
- Authors
- García-Amador, M., Pacchiarotti, I., Valentí, M., Sanchez, R. F., Goikolea, J. M., & Vieta, E.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2006-12
- Volume
- 6
- Issue
- 12
- Pages
- 1777-1783
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W1994457325
- Cited by
- 25
- References
- 36
- Citations by year
- 2025: 1 · 2024: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Neurotherapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- aripiprazole, atypical antipsychotics, mood disorders, bipolar disorder, mania, schizophrenia, schizoaffective disorder, lithium, divalproex, major depressive disorder, extrapyramidal symptoms, akathisia, drug tolerability
- MeSH terms
- Aripiprazole, Administration, Oral, Clinical Trials as Topic, Drug Administration Schedule, Humans, Practice Patterns, Physicians', Piperazines, Antipsychotic Agents, Quinolones, Treatment Outcome, Practice Guidelines as Topic, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
